Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
ABBVIE INC.
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
IPO Date: December 14, 2012
Sector: Healthcare
Industry: Drug Manufacturers
Market Cap: $306.02B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.97 | 1.02%
Avg Daily Range (30 D): $3.54 | 1.85%
Avg Daily Range (90 D): $2.50 | 1.31%
Institutional Daily Volume
Avg Daily Volume: 6.33M
Avg Daily Volume (30 D): 6.73M
Avg Daily Volume (90 D): 5.13M
Trade Size
Avg Trade Size (Sh.): 109
Avg Trade Size (Sh.) (30 D): 60
Avg Trade Size (Sh.) (90 D): 58
Institutional Trades
Total Inst.Trades: 60,098
Avg Inst. Trade: $9.37M
Avg Inst. Trade (30 D): $26.07M
Avg Inst. Trade (90 D): $23.71M
Avg Inst. Trade Volume: .09M
Avg Inst. Trades (Per Day): 19
Market Closing Trades
Avg Closing Trade: $86.42M
Avg Closing Trade (30 D): $298.21M
Avg Closing Trade (90 D): $245.24M
Avg Closing Volume: 793.22K
       
News
Apr 25, 2025 @ 9:17 PM
Why AbbVie Stock Topped the Market Today
Source: Eric Volkman
Apr 22, 2025 @ 9:37 PM
Why Vertex Pharmaceuticals Was Such a Healthy Stoc...
Source: Eric Volkman
Apr 20, 2025 @ 12:15 PM
Is AbbVie Stock a Buy?
Source: Justin Pope
Apr 18, 2025 @ 9:12 PM
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cerevel...
Source: Rosen, Global Investor Counsel
Apr 18, 2025 @ 8:26 AM
Atopic Dermatitis Drugs Market Forecast 2025-2034 ...
Source: Researchandmarkets.Com
Financials
  TTM Q3 2024 Q2 2024
Basic EPS $2.87 $.88 $.77
Diluted EPS $2.87 $.88 $.77
Revenue $ 55.53B $ 14.46B $ 14.46B
Gross Profit $ 37.32B $ 10.25B $ 10.26B
Net Income / Loss $ 5.13B $ 1.56B $ 1.37B
Operating Income / Loss $ 13.82B $ 3.83B $ 4B
Cost of Revenue $ 18.21B $ 4.21B $ 4.2B
Net Cash Flow $ -6030M $ -5873M $ -4937M
PE Ratio 64.79